Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
This makes the GCGR component particularly relevant for research into non-alcoholic fatty liver disease (NAFLD) models and energy balance studies
Obesity medications, such as GLP-1 receptor agonists, have rapidly changed the landscape of obesity and metabolic disease care, offering many patients meaningful weight loss and improved glycemic control
Grant TJ, Hua K, Singh A
& Butterfield, D
This reduces or eliminates the vast majority of the side effects as compared to direct hormonal treatment
US$ 23.61
US$ 22.99
US$ 26.64
US$ 24.61
US$ 29.48
